EN
登录

Xcell生物科学与Culture生物科学合作,利用人工智能和机器学习提升细胞治疗质量

Xcell Biosciences and Culture Biosciences Partner to Enhance Cell Therapy Quality Using AI and Machine Learning

PHARMA FOCUS ASIA 等信源发布 2025-12-10 13:38

可切换为仅中文


Xcell Biosciences has formed a partnership with Culture Biosciences.

Xcell生物科学公司与Culture生物科学公司建立了合作关系。

The collaboration aims to strengthen data analysis and accessibility for cell therapies developed or manufactured using the Xcellbio AVATAR™ Foundry system. The agreement enables customers to use Culture’s AI and machine-learning capabilities to gain deeper insights and improve their cell therapy processes..

该合作旨在加强使用Xcellbio AVATAR™ Foundry系统开发或制造的细胞疗法的数据分析和可访问性。根据协议,客户可以利用Culture的AI和机器学习能力来获得更深入的见解并改进其细胞治疗流程。

Xcellbio’s AVATAR platform supports cell and gene therapy research and development, while the AVATAR Foundry system is a cGMP manufacturing platform designed to enhance the potency of these therapies. Culture Biosciences offers Console™, a cloud-based software solution that helps teams remotely design, monitor, and analyse experimental data from multiple locations..

Xcellbio的AVATAR平台支持细胞和基因治疗的研究与开发,而AVATAR Foundry系统是一个旨在增强这些治疗效果的cGMP制造平台。Culture Biosciences提供Console™,这是一款基于云的软件解决方案,可帮助团队远程设计、监控和分析来自多个地点的实验数据。

Through this partnership, users of the AVATAR Foundry system will be able to access Culture’s cloud-native analysis tools to capture data from cell incubation, including temperature, oxygen, pH levels, and other process information. Teams can also track performance metrics across one or several systems and carry out detailed assessments using AI and machine learning to refine development and manufacturing workflows..

通过该合作,AVATAR Foundry系统的用户将能够访问Culture的云原生分析工具,以捕获细胞培养过程中的数据,包括温度、氧气、pH值和其他工艺信息。团队还可以跨一个或多个系统跟踪性能指标,并利用人工智能和机器学习进行详细评估,从而优化开发和制造流程。

The collaboration aims to support more personalised and predictive approaches in cell therapy, recognising that cells from different patients often require tailored conditions for optimal performance. Real-time monitoring and analysis are expected to help scientists adjust processes more accurately as therapies progress..

该合作旨在支持细胞治疗中更加个性化和预测性的方法,认识到不同患者来源的细胞通常需要定制的最佳条件。实时监测和分析有望帮助科学家在治疗进展过程中更精确地调整工艺。

Xcellbio plans to integrate additional sensors into the AVATAR Foundry system, allowing the capture of more data that can be processed through Console software. This is expected to give developers a deeper understanding of the therapies they produce. As AVATAR Foundry installations grow across different locations, cloud-based access is anticipated to support users in managing multiple systems efficiently..

Xcellbio计划将额外的传感器整合到AVATAR Foundry系统中,以捕获更多可通过Console软件处理的数据。这预计会让开发者对他们所生产的疗法有更深入的了解。随着AVATAR Foundry系统在不同地点的部署增加,基于云的访问预计将会帮助用户高效管理多个系统。

The partnership brings together Xcellbio’s expertise in advanced cell therapy platforms with Culture Biosciences’ capabilities in cloud computing, AI, and data analytics, aiming to improve the quality and consistency of cell therapy development.

该合作将Xcellbio在先进细胞治疗平台方面的专业知识与Culture Biosciences在云计算、人工智能和数据分析方面的能力相结合,旨在提高细胞治疗开发的质量和一致性。

Source: culturebiosciences.com

来源:culturebiosciences.com